Fertilin beta peptidic liposomes inhibit fertilization by steric blockage

Samidha Konkar1, Suparna Gupta, Nicole S Sampson

  • 1Department of Chemistry, State University of New York, Stony Brook, NY 11794-3400, USA.

Insights

Fertileliposomes containing fertilinbeta peptides inhibit mouse fertilization by physically blocking sperm access to egg receptors. This mechanism requires few multivalent contacts for effective inhibitor attachment to the egg membrane.

Area of Science:

  • Reproductive Biology
  • Biochemistry
  • Nanotechnology

Background:

  • Fertilizinbeta peptides are crucial for mammalian fertilization.
  • Liposomes are versatile drug delivery systems with potential in reproductive medicine.
  • Understanding the mechanism of fertilization inhibition is key for developing new contraceptive strategies.

Purpose of the Study:

  • To investigate the relationship between liposome composition and fertilinbeta peptide concentration in inhibiting mouse in vitro fertilization.
  • To determine the size-dependent effects of fertilinbeta peptide-presenting liposomes on fertilization.
  • To elucidate the mechanism by which these liposomes inhibit sperm-egg interaction.

Main Methods:

  • In vitro fertilization assays using mouse gametes.
  • Liposome preparation with varying concentrations and sizes of fertilinbeta peptides.
  • Analysis of IC(50) values and mole fraction of fertilinbeta peptides.
  • Microscopic observation of sperm-egg binding and penetration.

Main Results:

  • Liposomes presenting fertilinbeta peptides effectively inhibited mouse in vitro fertilization.
  • A small number of multivalent contacts were sufficient for inhibitor attachment to the egg membrane.
  • Liposomes were shown to target the egg membrane specifically, not the sperm membrane.
  • Liposome size influenced inhibition, indicating a physical blocking mechanism.

Conclusions:

  • Fertilizinbeta peptide-liposomes act as potent inhibitors of mouse fertilization.
  • The inhibition mechanism involves physical obstruction of sperm access to the egg membrane.
  • Liposome-based delivery of fertilinbeta peptides offers a targeted approach for fertilization inhibition.

Related Concept Videos

Fertilization01:38

Fertilization

During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...